Anika Therapeutics | ANIK - Actif À Court Terme

Prix De L'Action
14.81
Variation Quotidienne
0.05 0.34%
Mensuellement
3.13%
Annuel
6.62%
Q2 Prévisions
14.36




Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
Agenus USD 133.44M 514K 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Anika Therapeutics USD 103.36M 1.77M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Merit Medical Systems USD 1.04B 54.62M 2025-12
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 75.99M 5.31M 2025-06
Veracyte USD 488.38M 39.15M 2025-12
Xencor USD 599.82M 81.38M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12